Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer

Exp Mol Med. 2022 Nov;54(11):1940-1954. doi: 10.1038/s12276-022-00877-y. Epub 2022 Nov 11.

Abstract

Pancreatic cancer (PC) is one of the most malignant tumors. Rapid progression and distant metastasis are the main causes of patient death. Hypoxia is a hallmark of multiple cancers and is involved in tumor biology. However, little is known about the roles of circRNAs in glycolysis and hypoxia-mediated progression of PC. Here, the expression pattern of hypoxia-related circRNAs was analyzed using RNA sequencing. A unique circRNA termed circRNF13 was found to be upregulated in PC tissues and may be a potential prognostic indicator. HIF-1α and EIF4A3 are involved in regulating the biogenesis of circRNF13. Furthermore, circRNF13 was validated to exert a stimulative effect on cell proliferation, angiogenesis, invasion and glycolysis. Importantly, we found that circRNF13 promoted PDK3 levels by acting as a miR-654-3p sponge, thus promoting the PC malignant process. Collectively, our results reveal that hypoxia-induced circRNF13 mediated by HIF-1α and EIF4A3 promotes tumor progression and glycolysis in PC, indicating the potential of circRNF13 as a prognostic biomarker and therapeutic target for PC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glycolysis / genetics
  • Humans
  • Hypoxia / metabolism
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Pancreatic Neoplasms* / metabolism
  • RNA, Circular / genetics

Substances

  • RNA, Circular
  • MicroRNAs